Trial Profile
Effect of a Combination of Daclatasvir, Asunaprevir, and BMS-791325 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Beclabuvir; Ethinylestradiol/norethisterone
- Indications Acne vulgaris; Hepatitis C; Pregnancy
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 14 Aug 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2014 New trial record